PPL-X1

medicines, drugs and active synthetic peptides used for the prevention and treatment of inflammatory diseases, autoimmune diseases, immune-mediated diseases, infectious diseases, diseases of the central nervous system ("CNS") and abatement of acute and chronic rejection of tissue and organ in transplant recipients